A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients
about
Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published EvidenceEconomic impact of biologic utilization patterns in patients with psoriatic arthritisTristetraprolin as a Therapeutic Target in Inflammatory DiseaseSingle-Arm Study of Etanercept in Adult Patients with Moderate to Severe Rheumatoid Arthritis Who Failed Adalimumab Treatment.Treatment patterns of biologics in US patients with ankylosing spondylitis: descriptive analyses from a claims database.Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database.
P2860
A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Retrospective Cohort Study C ...... Adult US Managed Care Patients
@en
type
label
A Retrospective Cohort Study C ...... Adult US Managed Care Patients
@en
prefLabel
A Retrospective Cohort Study C ...... Adult US Managed Care Patients
@en
P2093
P2860
P1433
P1476
A Retrospective Cohort Study C ...... Adult US Managed Care Patients
@en
P2093
Benjamin Chastek
Bradley S Stolshek
Damon Van Voorhis
Derek Tang
John White
P2860
P2888
P304
P356
10.1007/S12325-016-0312-Y
P407
P577
2016-03-12T00:00:00Z